$2.780
+0.010 (+0.36%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de NEUP por análisis de gráficos similares
Alphio's NEUP stock price prediction model matches the current Neuphoria Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.88 (+3.61%). The 1-week path is $2.90 (+4.45%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Neuphoria Therapeutics Inc?
Neuphoria Therapeutics Inc. is not a good buy right now due to its declining financial performance and negative market sentiment. The stock has dropped 43.27% over the past year and currently has an RSI of 9.449, indicating it is oversold but also reflects a lack of buying interest. The forward P/E ratio is 0, suggesting uncertainty in future earnings, and recent news about Merck halting a key drug trial has negatively impacted investor confidence, leading to a 19% drop in NEUP's stock price. The main risk is the significant 8.85% decline in the stock over the last 5 days, which indicates continued downward momentum.
NEUP cerró en $2.78 el Friday, tras subir +0.36%
Neuphoria Therapeutics Inc (NEUP) last closed at $2.78, gaining +0.36%. These facts feed the 1-day and 1-week NEUP price prediction above.
Factores de la previsión
Los factores de la previsión de Neuphoria Therapeutics Inc (NEUP) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de NEUP, ordenadas por similitud.
Análisis de estacionalidad de NEUP
Historically the probability of a positive November return for NEUP is 43.18%. June offers the highest probability of a positive month at 68.33%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de NEUP
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $6.83 | $8.21 | $9.32 | +195.36% |
| Dec 2026 | $7.47 | $8.30 | $9.69 | +198.64% |
En 2026, se proyecta que Neuphoria Therapeutics Inc (NEUP) oscile entre $6.83 y $9.69.
Previsión mensual de Neuphoria Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Neuphoria Therapeutics Inc promedie $8.21, con un mínimo de $6.83 y un máximo de $9.32.
En Dec de 2026, se proyecta que Neuphoria Therapeutics Inc promedie $8.30, con un mínimo de $7.47 y un máximo de $9.69.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.